Filters
At the Microbiome Summit 2026, experts shared insights into how the gut microbiome can be modulated to support healthy ageing.
Preterm infants receiving kangaroo mother care (KMC) exhibit different patterns of growth, but most of them have appropriate first-year growth, according to a study.
In patients with non–large vessel occlusion acute ischemic stroke and salvageable brain tissue, administering intravenous tenecteplase between 4.5 and 24 h after stroke onset helps increase the chances of having an excellent functional outcome, although it contributes to an increased risk of symptomatic intracranial haemorrhage, according to a study.
Smoking cannabis appears to reduce the consumption of alcohol under some conditions, but it remains unclear whether this would lead to a decrease in harms, reports a study.
Laser-based red light therapy instruments used as an intervention for myopia have been found to deliver irradiance levels that exceed the American National Standards Institute (ANSI) safety limits within exposure times below the recommended 180-s treatment time, as reported in a quality improvement study.
For patients with acute ischaemic stroke caused by a large-vessel occlusion, infusing alteplase into the artery after successful endovascular thrombectomy is beneficial, conferring functional gains and reducing persistent hypoperfusion, as shown in the phase III open-label CHOICE-2 trial.
A mobile phone application (app), FatSecret, appears more effective than traditional, validated 3-day food record in stimulating weight loss and metabolic improvements among adolescents with obesity, suggests a recent study.
A recent study has shown the effectiveness and precision of semi-solid extrusion (SSE) 3D printing in producing various formulations of ondansetron HCl dihydrate in hospital pharmacies.
Antipsychotic drugs remain the standard treatment for schizophrenia, but experts flag their relative efficacy and side effects. In addition, guideline recommendations on efficacy differences are unclear, according to a study.
Many patients with triple-negative breast cancer (TNBC) have a lower tolerated dose of capecitabine relative to the recommended adjuvant dose, a study has shown.
